Lack of improvement of oral absorption of ME3277 by prodrug formation is ascribed to the intestinal efflux mediated by breast cancer resistant protein (BCRP/ABCG2). (Q40431648)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lack of improvement of oral absorption of ME3277 by prodrug formation is ascribed to the intestinal efflux mediated by breast cancer resistant protein (BCRP/ABCG2). |
scientific article |
Statements
1 reference
Lack of improvement of oral absorption of ME3277 by prodrug formation is ascribed to the intestinal efflux mediated by breast cancer resistant protein (BCRP/ABCG2). (English)
1 reference
Chihiro Kondo
1 reference
Reiko Onuki
1 reference
Hiroyuki Kusuhara
1 reference
Hiroshi Suzuki
1 reference
Michiko Suzuki
1 reference
Noriko Okudaira
1 reference
Maho Kojima
1 reference
Kazuya Ishiwata
1 reference
Yuichi Sugiyama
1 reference
7 April 2005
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference